Literature DB >> 8995640

Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter.

S Ressler1, G F Morris, S J Marriott.   

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) transforming protein, Tax, is a potent transactivator of both viral and cellular gene expression. The ability of Tax to transform cells is believed to depend on its transactivation of cellular-growth-regulatory genes. Expression of proliferating cell nuclear antigen (PCNA) is intimately linked to cell growth and DNA replication and repair. By testing a series of PCNA promoter deletion constructs, we have demonstrated that the PCNA promoter can be transactivated by Tax. The smallest construct that was activated did not include the ATF/CRE binding site at nucleotide -50, and mutations in the ATF/CRE element in the context of a larger promoter were still activated by Tax. In addition, a Tax mutant that is defective for activation of the CRE pathway retained the ability to activate the -397 promoter construct. When a series of linker scanner mutations that span the region from nucleotide -45 to -7 were assayed, mutations in and around a repeat sequence were found to abolish Tax transactivation. Multimerized copies of either half of the repeat were Tax responsive. A single protein complex was shown to bind specifically to the Tax-responsive region, and the binding of this complex was enhanced in the presence of Tax. These results demonstrate that the PCNA promoter contains a Tax-responsive element located between nucleotides -45 and -7 whose sequence is different from those of other, previously identified Tax-responsive elements. The ability of Tax to activate the PCNA promoter may play an important role in cellular transformation by HTLV-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995640      PMCID: PMC191171     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer.

Authors:  H Paskalis; B K Felber; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells.

Authors:  J E Celis; R Bravo; P M Larsen; S J Fey
Journal:  Leuk Res       Date:  1984       Impact factor: 3.156

3.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

4.  An auxiliary protein for DNA polymerase-delta from fetal calf thymus.

Authors:  C K Tan; C Castillo; A G So; K M Downey
Journal:  J Biol Chem       Date:  1986-09-15       Impact factor: 5.157

5.  Indirect immunofluorescence studies of proliferating cell nuclear antigen in nucleoli of human tumor and normal tissues.

Authors:  P K Chan; R Frakes; E M Tan; M G Brattain; K Smetana; H Busch
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

6.  Promoter activity of the proliferating-cell nuclear antigen gene is associated with inducible CRE-binding proteins in interleukin 2-stimulated T lymphocytes.

Authors:  D Huang; P M Shipman-Appasamy; D J Orten; S H Hinrichs; M B Prystowsky
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

7.  Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme.

Authors:  H Flores-Rozas; Z Kelman; F B Dean; Z Q Pan; J W Harper; S J Elledge; M O'Donnell; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

8.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Type I human T cell leukemia virus tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway.

Authors:  M R Smith; W C Greene
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more
  27 in total

1.  Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Authors:  Philip J Norris; Dale F Hirschkorn; Deborah A DeVita; Tzong-Hae Lee; Edward L Murphy
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

Review 2.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

3.  Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR.

Authors:  Min Li; Patrick L Green
Journal:  J Virol Methods       Date:  2007-03-06       Impact factor: 2.014

Review 4.  Effect of transforming viruses on molecular mechanisms associated with cancer.

Authors:  Tajhal Dayaram; Susan J Marriott
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

5.  Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB/ATF activation fail to transform primary human T cells.

Authors:  T M Ross; M Narayan; Z Y Fang; A C Minella; P L Green
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model.

Authors:  T Portis; W J Grossman; J C Harding; J L Hess; L Ratner
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  XBP-1, a novel human T-lymphotropic virus type 1 (HTLV-1) tax binding protein, activates HTLV-1 basal and tax-activated transcription.

Authors:  Sebastian C Y Ku; Jialing Lee; Joanne Lau; Meera Gurumurthy; Raymond Ng; Siew Hui Lwa; Joseph Lee; Zachary Klase; Fatah Kashanchi; Sheng-Hao Chao
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

8.  Human T-cell leukemia virus type 2 Rex carboxy terminus is an inhibitory/stability domain that regulates Rex functional activity and viral replication.

Authors:  Li Xie; Matthew Kesic; Brenda Yamamoto; Min Li; Ihab Younis; Michael D Lairmore; Patrick L Green
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

9.  Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Hanxin Lu; Cynthia A Pise-Masison; Rebecca Linton; Hyeon Ung Park; R Louis Schiltz; Vittorio Sartorelli; John N Brady
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Phosphorylation regulates human T-cell leukemia virus type 1 Rex function.

Authors:  Matthew Kesic; Rami Doueiri; Michael Ward; O John Semmes; Patrick L Green
Journal:  Retrovirology       Date:  2009-11-17       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.